Skip to main content

ADVERTISEMENT

Charles Shinaver, PhD

The SHARP trial evaluated solriamfetol's effect on cognitive function in patients with obstructive sleep apnea (OSA) and excessive daytime sleepiness (EDS)-related cognitive impairment. T...
10/26/2023